Ludwig Scientists Share Findings on Development and Treatment of Glioblastoma at the 2017 Society for Neuro-Oncology Annual Meeting
Ludwig Cancer Research has released the scope of its participation at this year’s Annual Meeting and Education Day of the Society for Neuro-Oncology in San Francisco, California, November 16-19.
13-Nov-2017 9:00 AM EST Add to Favorites
Ludwig Researchers Uncover Novel Mechanism by Which Tumors Evade a Variety of Cancer Immunotherapies
A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy.
10-Nov-2017 9:00 AM EST Add to Favorites
Ludwig Scientists Share Insights on Immunotherapy Research at the 2017 Society for Immunotherapy of Cancer Annual Meeting
Ludwig Cancer Research has released the scope of its participation at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, Maryland, November 8-12.
6-Nov-2017 3:45 PM EST Add to Favorites
A Ludwig Cancer Research study has uncovered a new mechanism by which cancer cells evade destruction by the immune system. The paper, led by Camilla Jandus of the Lausanne Branch of the Ludwig Institute for Cancer Research, describes how immune...
19-Sep-2017 9:00 AM EDT Add to Favorites
Ludwig researchers show how a method that physically expands tissues can improve early breast cancer diagnostics and extend the capabilities of ordinary pathology labs
17-Jul-2017 11:00 AM EDT Add to Favorites
Ludwig Researchers Present New Findings on Combination Immunotherapy and Other Research at the 2017 ASCO Annual Meeting
Ludwig Cancer Research released today the full scope of Ludwig’s participation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2-6.
31-May-2017 9:00 AM EDT Add to Favorites
The loss of the tumor suppressor gene PTEN has been linked to tumor growth and chemotherapy resistance in the almost invariably lethal brain cancer glioblastoma multiforme (GBM). Now, Ludwig researchers have shown that one way to override the...
12-May-2017 9:00 AM EDT Add to Favorites
Ludwig Scientists Reveal New Advances in Immunotherapy, Biomarkers and Treatment Resistance at 2017 AACR Annual Meeting
Ludwig Cancer Research released today the full scope of advances to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Washington D.C., April 1-5, 2017.
29-Mar-2017 3:30 PM EDT Add to Favorites